Antibodies to a nucleolar protein are localized in the nucleolus after red blood cell-mediated microinjection by unknown
Antibodies to a 
Nucleolus after 
Nucleolar Protein Are Localized  in the 
Red  Blood  Cell-mediated  Microinjection 
FRANK C.  BENNETT, HARRIS BUSCH, MICHAEL  A.  LISCHWE, and 
LYNN C.  YEOMAN 
Nuclear Protein Laboratory, Department of Pharmacology, Baylor College of Medicine, 
Houston, Texas 77030 
ABSTRACT  TO determine whether red blood cell-mediated  microinjection  of antibodies  can 
be used to study nuclear protein  localization and function,  we microinjected  antibodies  that 
have been shown to react specifically with nucleolar acidic phosphoprotein  C23 into Walker 
256 cells. The intracellular  distribution  of microinjected  anti-C23 antibodies  and preimmune 
immunoglobulins  were  determined  by  immunofluorescence.  At  3  h  after  microinjection, 
affinity-purified  anti-C23  antibodies  were localized  in the cytoplasm  and nucleolus. At 17 h 
after microinjection,  the affinity-purified  antibody was localized to those nucleolar structures 
previously  shown to contain  protein  C23. Furthermore,  the antibody remained  localized  in 
the  nucleolus  for at least 36 h after  microinjection.  In contrast to the  results obtained  with 
specific  antibodies,  preimmune  immunoglobulins  remained  in  the  cytoplasm  36  h  after 
microinjection.  These results indicate that red blood cell-mediated  microinjection  of antibodies 
can be used to study nucleolar and nuclear antigens. 
The introduction of individual proteins into cells by microin- 
jection is a useful procedure for determining their functions 
in living cells (4, 6, 9,  12,  17, 18, 31, 38). Two methods have 
been  used  to  microinject proteins  into  living  cells:  direct 
microneedle microinjection (8, 14) and red blood cell (RBC) ~- 
mediated microinjection (13,  22,  34).  The advantages and 
disadvantages of  these techniques have been reviewed (5, 30). 
An alternative approach to microinjection of the protein of 
interest is microinjection of specific antibodies, with the ob- 
jective of inhibiting the function of the protein (1, 20, 23, 25, 
26, 28, 32, 33, 39). 
In previous studies nuclear proteins were microinjected into 
the cytoplasm of cells either by the microneedle method or 
by RBC-mediated fusion. Subsequently, the injected proteins 
passed through the nuclear envelope into the cell nucleus (2, 
3, 7, 9, 11, 31, 38, 40). The movement of  non-nuclear proteins 
from the cytoplasm to the nucleus appears to be regulated in 
part  by  size  (2).  Thus,  small  proteins  such  as  myoglobin 
(17,000 mol wt) distribute evenly between the nucleus and 
cytoplasm, whereas larger proteins such as BSA (67,000 mol 
wt) or immunoglobulins (150,000 mol wt) enter the nucleus 
slowly, or not at all (2). However, size does not totally limit 
the ability of proteins to penetrate the nuclear envelope since 
nucleus,  nonimmune  immunoglobulins and  antibodies di- 
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the nucleus is known to contain many high molecular weight 
nuclear proteins (3). 
Although the results of previous studies would suggest that 
the nuclear envelope excludes immunoglobulins from the cell 
nucleus,  nonimmune  immunoglobulins and  antibodies di- 
rected against non-nuclear antigens have been used to evalu- 
ate nuclear exclusion (2, 25). This approach would not, how- 
ever, detect uptake and retention of small but possibly mean- 
ingful amounts of antinuclear antibodies. Therefore, to fur- 
ther evaluate the applicability of RBC-mediated microinjec- 
tion of antinuclear antibodies, we have investigated whether 
specific  immunoglobulins can  penetrate the  nuclear mem- 
brane and remain localized at sites that contain their antigens. 
Antibodies to the nucleolar specific phosphoprotein C23 (21, 
24)  and  preimmune  immunoglobulins were  microinjected 
into Walker 256 cells, a rat mammary carcinoma. The local- 
ization of the  microinjected antibodies was  determined by 
immunofluorescence. Possible mechanisms for the entry of 
nucleolar-specific antibodies into the cell nucleus, and their 
subsequent retention are discussed. 
MATERIALS AND  METHODS 
Preparation of Antibodies:  Protein C23 was isolated from rat No- 
vikoff  hepatoma nucleoli as previously described (21). The purified protein was 
used to produce rabbit polyclonal antibodies (21). The serum Ig fraction was 
prepared  by  standard ammonium sulfate precipitation.  For  microinjection 
THE JOURNAL OF  CELL BIOLOGY • VOLUME 97  NOVEMBER 1983  1556-1572 
© The Rockefeller University Press . 0021-9525/83/1 I/I 566•07  $1.00 experiments, the lg fraction was dialyzed against 10 mM Tris HCI pH 7.4 and 
concentrated  to  16  mg/ml. The specificity of antibodies  was determined  by 
Ouchterlony immunodiffusion  analysis (21), enzyme-linked immunoadsorbent 
assay (10), and immunoblotting (36) as described below. 
Affinity-purified antibodies  were prepared  from immunized rabbit  serum. 
Purified protein C23 was coupled to CNBr-activated Sepharose 4B (Pharmacia, 
Uppsala, Sweden). Antiserum  to protein  C23 was applied to the column and 
the column was washed with 0.5 M NaCl/0.1  M NaHCO3, pH 8.3. The bound 
antibody  was eluted with 4 M MgCl2, dialyzed into PBS (150 mM NaCl/10 
mM sodium phosphate, pH 7.4), and precipitated with 50% saturated  ammo- 
nium sulfate. The antibody was redissolved in l0 mM Tris HCI, pH 7.4, to a 
final concentration  of 5 mg/ml. 
Monoclonal  antibodies  to  rat  nueleolar  protein  C23  were  produced  by 
standard techniques (l 6, 29). BALB/c mice were immunized by subcutaneous 
injection with 300-500 ~g of antigen mixed in Freund's complete adjuvant six 
times over a period of 12 wk. Spleen cells were fused with NSI myeioma cells 
using  30%  polyethylene  glycol. Positive  clones  were identified  by enzyme- 
linked  immunoadsorbent assay and subsequently  by immunoblotting as de- 
scribed below. 
Immunoblot Assays:  Immunoblots  were performed using whole No- 
vikoff hepatoma nueleoli as the source of the antigen. Nucleoli were suspended 
in Laemmli  sample  buffer (19), heated  for 5 min at  100*C, and an aliquot 
containing  150 tLg of protein was applied to either an 8 or I 1% SDS polyacryl- 
amide gel (19). After electrophoresis the proteins were transferred to nitrocel- 
lulose paper (36) and the paper was cut into  strips corresponding  to the gel 
lanes. These were stained with amido black or with antiprotein  C23 antibodies 
(36).  The immunoreactions were  performed  on the  nitrocellulose  paper as 
previously described (27). Rabbit  antibodies were diluted  1:2,500 and mouse 
monoclonal antibody to protein C23 was diluted  1:50. 
Cells and Cell Culture:  The Walker 256 rat mammary carcinoma 
cell line was obtained from the American Type Culture Collection (Rockville, 
MD). Cells were cultured  in Dulbecco's modified  Eagle's minimum essential 
medium containing 4.5 g glucose/liter (Gibco Laboratories, Grand Island, NY) 
supplemented  with  l  mM  sodium pyruvate,  2  mM  L-glutamine, 0.1  mM 
minimum essential medium nonessential amino acids, and 5% fetal calf serum 
(M. A. Bioproducts, Walkersville, MD). 
RBC-mediated  Microinjection:  Stock  cultures  of Sendai  virus 
were a gift from Dr. Martin  Rechsteiner (University of Utah, Salt Lake City). 
Loading of human red blood cells and fusion of loaded RBC to Walker 256 
cells were performed as described by Schlegel and Rechsteiner (35). The fusion 
mixture contained  109 loaded  RBC,  107 Walker 256 cells, and  1,000-2~000 
hemagglutinating  units of UV  inactivated  Sendal  virus.  The  efficiency of 
microinjection,  determined  by immunofluorescence,  ranged from 40 to 80%. 
Unfused  RBC  were separated  from rat carcinoma  cells by layering the cell 
suspension over l0 ml of 50%  fetal calf serum followed by centrifugation  at 
250 g for 3.5 min. This procedure  was repeated once. Cells were plated either 
in two chamber microscope slides (Lab-Tek Products, Naperville, IL) or on 22 
x 22-mm cover slips in 35-ram petri dishes. 
Immunofluorescence:  Cells attached  to microscope slides or cover 
slips were washed twice in PBS and fixed for 20  min in 2%  methanol-free 
paraformaldehyde (Polysciences Inc., Wan'ington, PA). The cells were permea- 
bilized with acetone (-20"C) for 3.5 rain and washed again in PBS for 20 min. 
For indirect immunofluorescence,  ceils were incubated  with the primary anti- 
body  diluted  in  Dulbecco's  modified  Eagle's  minimum essential  medium 
containing  5% fetal calf serum for 1 h at 37"C in a humidified chamber. The 
cells were  washed  in  several changes  of PBS  for  30  rain,  followed by  an 
incubation  for  1 h with either a  1:100 dilution  of fluoreseein isothiocyanate- 
conjugated  goat  anti-rabbit  IgG,  fluorescein  isothiocyanate-conjugated  goat 
anti-mouse Ig or a 1:50 dilution of rhodamine-eonjugated  goat anti-rabbit lgG 
(Cappel  Laboratories,  Inc., Cochranville,  PA). Cells were then incubated  in 
four changes of PBS, 15 min each, at room temperature,  then for 16 h at 4"C. 
The cover slips were mounted with glyeerol/PBS containing  p-phenylenedi- 
amine (Sigma Chemical  Co., St. Louis, MO) as described by Johnson et at. 
(15). Antibodies microinjected into cells were localized by immunofluorescenee 
as described above, except that the fixation time with paraformaldehyde  was 
reduced to 15 min and incubation  with primary antibodies was omitted. 
RESULTS 
Antibody Specificity 
The  specificities  of the  rabbit  polyclonal  antibody  and 
mouse  monoclonal  antibody  for protein  C23  are  demon- 
strated in Fig.  1. Lanes A and C are the amido black stains of 
total  nucleolar proteins transferred to  nitrocellulose paper 
FIGURE  1  Immunoblot analysis of antibody specificity. Total nu- 
cleolar proteins were separated on either 8 (lanes A and B) or 11% 
(lanes C and D) SDS  polyacrylamide gels and  electrophoretically 
transferred to  nitrocellulose paper (36). The  nitrocellulose strips 
were stained with amido black (lanes A  and C)  or reacted with 
antibodies and  ~2Sl-protein A  (lanes B and D) as described in  the 
Materials and Methods.  Lanes B and D  were reacted with rabbit 
antiprotein C23  serum  and  mouse  antiprotein C23  monoclonal 
antibody respectively. The molecular weight ordinate applies only 
to lanes C and D. 
from 8 and  11% polyacrylamide gels, respectively. In lane B 
an autoradiograph of the immunoreaction of the rabbit pol- 
yclonal antibody with total nucleolar proteins demonstrates 
the specificity of the antibody for protein C23.  The corre- 
sponding  immunoreaction of the  mouse  monoclonal anti- 
body demonstrates that protein C23 is also the only protein 
recognized by this antibody (lane D). 
The phase contrast and corresponding fluorescent images 
demonstrating the localization of protein C23  in  rat carci- 
noma cells by indirect immunofluorescence are shown in Fig. 
2.  Preimmune  immunoglobulins  used  for  microinjection 
failed to exhibit specific  staining of cellular structures (Fig. 
2 b). Both the rabbit polyclonal and mouse monoclonal anti- 
bodies specifically reacted with nucleolar structures (Fig. 2, d 
and f), demonstrating that protein C23 is a nucleolar specific 
protein in these cells. Furthermore, the nucleolar staining was 
eliminated if the rabbit serum was preincubated with protein 
C23  (21),  again  demonstrating the  specificity of the rabbit 
antibody for protein C23. These results agree with the locali- 
zation of protein C23 in other cell types (21, 27). It should be 
noted that the nucleoli of Walker 256 cells  are variable in 
morphology and often contain multiple nucleoli (Fig. 2, a, c, 
and e). 
Microinjection  of Antibodies 
To determine whether  RBC-mediated  microinjection of 
antibodies could be used to study nuclear protein localization 
and function, antibodies to protein C23 were microinjected 
into Walker 256 cells. As a control, cells were also microin- 
jected with an Ig fraction of preimmune rabbit serum. Cells 
BENNETt ET AL.  Localization of Antibodies  to a Nucleolar Protein  1567 FIGURE  2  Localization of nucleolar protein C23 in rat carcinoma cells by indirect immunofluorescence. Phase contrast (a, c, and 
e) and corresponding indirect immunofluorescence (b, d, and f } images of cells labeled with  preimmune immunoglobulins (b), 
affinity-purified  rabbit antiprotein C23  antibodies (d),  or  antiprotein C23  mouse monoclonal antibodies ([),  as  described  in 
Materials and Methods. x  300. 
microinjected with antibodies were fixed at  3,  17,  or 36  h 
after microinjection, and the immunoglobulins were localized 
with fluorescein-conjugated goat anti-rabbit IgG. At 3 (data 
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not  shown)  and  17  h  (Fig.  3a)  preimmune IgG molecules 
were localized in the cytoplasm. Weak fluorescence was ob- 
served in the nuclei of some cells,  which could reflect low- FIGURE 3  Localization of microinjected antibodies. Antibodies were microinjected into rat carcinoma  ceils and subsequently 
localized by  immunofluorescence as  described  in  the  Materials  and  Methods.  (a)  Preimmune immunoglobulins 17  h  after 
microinjection; (b) affinity-purified antiprotein C23 antibodies 3 h after microinjection; (c) phase contrast, and (d) immunofluo- 
rescence of affinity-purified antibodies 17 h after microinjection; and (e) phase and (f) immunofluorescence of affinity-purified 
antibodies 36 h after microinjection. 
level entry of IgG into the nucleus or IgG in the cytoplasm 
directly over the nucleus.  By 36 h after microinjection, fluo- 
rescence was greatly diminished, probably due to dilution of 
the immunoglobulins with the cytoplasmic material when the 
cells divide (data not shown); however, the  fluorescence re- 
mained cytoplasmic. These results confirm those results pre- 
viously reported by Bonner (2) and McGarry et al. (25). 
Localization of microinjected antiprotein  C23  antibodies 
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immunoglobulins (Fig. 3 a). Immunofluorescence  localization 
of the  microinjected antibody resulted in  cytoplasmic and 
nucleolar fluorescence with little nucleoplasmic fuorescence, 
both at 3 and at  17 h after microinjection (data not shown). 
To determine how much cytoplasmic fluorescence was due 
to nonspecific immunoglobulins, protein C23 antibodies were 
affinity-purified as described in Materials and Methods. 3 h 
after microinjection, the affinity-purified antibody was local- 
ized in  the  cytoplasm and  nucleolus of the  cell (Fig.  3b), 
similar to the result obtained for the Ig fraction of antiserum 
against protein C23.  However, by 17 h the affinity-purified 
antibody was localized almost exclusively to the  nucleolus 
(Fig. 3 d), producing a fluorescence staining pattern in those 
cells  that  were  microinjected similar  to  that  obtained  by 
indirect  immunofluorescence (Fig.  2d).  Furthermore,  the 
antibodies remained in the nucleolus for at least 36 h  after 
microinjection (Fig. 3f). Because we have observed nucleolar 
fluorescence in 95% of the cells microinjected with affinity- 
purified antibody at 3 h after microinjection, it appears that 
IgG molecules were able to penetrate the nuclear envelope. 
Their rate of entry into the nucleus, however, was apparently 
limited because it took several hours to achieve maximum 
fluorescence. Our data suggest that once antibodies are bound 
to nucleolar structures, they remain associated for at least 36 
h. 
To determine whether the localization of the microinjected 
antibodies corresponded to those structures that contain pro- 
tein C23, the following experiment was performed. Affinity- 
purified antibodies to protein C23 were microinjected into 
cells; the cells were fixed 17 h after microinjection and sub- 
sequently  incubated  with  mouse  monoclonal  antibody  to 
protein C23. The cells were then double-labeled with fluores- 
cein isothiocyanate-conjugated goat anti-mouse and rhoda- 
mine-conjugated goat anti-rabbit antibodies.  The immuno- 
fluorescent staining  observed with  monoclonal antiprotein 
C23 antibody showed,  as in  Fig.  2f, that  protein C23  was 
localized in nucleoli (Fig. 4 b), including small juxtanucleokir 
structures (arrows). In those cells that were microinjected with 
affinity-purified antiprotein  C23  antibodies  (Fig.  4a),  the 
antibodies localized in the same nucleolar and juxtanucleolar 
structures. The three cells in Fig. 4 a that do not show nucleo- 
lar fluorescence were not microinjected. The three microin- 
jected cells in Fig. 4 b are labeled with the mouse monoclonal 
antibody to the same extent as noninjected cells, suggesting 
that the microinjected antibody is substoichiometric to pro- 
tein C23 in the nucleolus. We have not attempted to microin- 
ject the mouse monoclonal antibody to protein C23. 
To determine whether the  microinjected antibodies pass 
through the nuclear envelope complexed with newly synthe- 
sized  protein  C23,  we  microinjected affinity-purified anti- 
bodies into  cells  in  which  >90%  of protein  synthesis was 
inhibited with  1.0 ug/ml cycloheximide. Cells were preincu- 
bated for 30 rain in the presence of 1.0 vg/ml cycloheximide, 
FIGURE  4  Localization of protein C23 in cells microinjected with antiprotein C23 antibodies. Rat carcinoma cells were microin- 
jected with  affinity-purified  rabbit antiprotein  C23  antibodies. Cells were fixed  17  h  after  microinjection and  incubated  with 
mouse monoclonal antibody as described in Materials and Methods. Antibodies were localized by double indirect immunofluo- 
rescence  using  rhodamine-conjugated  goat  anti-rabbit  IgG  and  fluorescein-conjugated  goat  anti-mouse  Ig.  (a)  Rhodamine 
fluorescence demonstrating localization of microinjected antibodies; (b) fluorescein fluorescence demonstrating localization of 
endogenous protein C23 in microinjected cells, as well as noninjected cells, x  1,030. 
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noma cells incubated with cycloheximide. Cells were preincubated 
for 30 min with 1.0/~g/ml cycloheximide, microinjected with affin- 
ity-purified protein C23  antibodies, and further incubated in the 
presence  of  cycloheximide for  17  h  as  described  in  the  text. 
Antibodies were localized by immunofluorescence as described in 
Materials and Methods. Phase contrast (a) and immunofluorescent 
image (b) of cells 17 h after microinjection, x  185. 
microinjected with affinity-purified anti-C23  antibody, then 
incubated for either 3 or  17 h  in the presence of cyclohexi- 
mide. To insure that protein synthesis was inhibited during 
the microinjection procedure, all buffers contained 1.0 ug/ml 
cycloheximide. The localization of the antibody was similar 
in control and cycloheximide-treated cells at both time points. 
By 17 h, the antibody was localized primarily in the nucleolus 
as shown in  Fig.  5.  Thus, it does not seem likely that anti- 
bodies  enter  the  nucleus  complexed to  newly  synthesized 
proteins. 
DISCUSSION 
This study shows that preimmune IgG molecules, microin- 
jected into rat carcinoma cells by RBC-mediated microinjec- 
tion,  remain  localized  in  the  cytoplasm  up  to  36  h  after 
microinjection, in agreement with previous reports (2, 25). It 
has been reported that bovine lgG molecules microinjected 
into Friend erythroleukemia cells associate with nuclei (37), 
but it is not clear whether these molecules actually entered 
the  nucleus or bound to the  nuclear membrane during cell 
fractionation (37). 
In contrast  to  the  results  obtained with  preimmune IgG 
molecules, we found that antibodies to nucleolar protein C23 
penetrated the nuclear envelope. Affinity-purified antibodies 
were found in the cytoplasm and nucleolus 3 h after microin- 
jection.  By  17 h  the antibodies were localized almost exclu- 
sively in the nucleolus, with little antibody in the cytoplasm 
or nucleoplasm.  Several  possibilities could  account  for the 
appearance of the protein C23 antibodies in the nucleus while 
preimmune  immunoglobulins  were  excluded.  First,  if the 
fixation of microinjected cells was insufficient, it is possible 
that,  when  the  cells were  permeabilized with  acetone,  free 
antibodies could diffuse into  the  nucleus  and bind protein 
C23 in the nucleolus. Arguing against this possibility is that 
there was a shift in the localization of the antibody from the 
cytoplasm to the nucleolus with time following microinjection 
(Fig. 3, b and d). Because the cells were fixed identically at all 
times points, this shift in localization can not be attributed to 
the  fixation  conditions.  Furthermore,  increasing  fixation 
times from  15 to 30 min did not change the distribution of 
microinjected antibodies (data not shown). 
A second possibility is that protein C23 antibodies bind to 
protein  C23  during  mitosis,  when  the  nuclear  envelope is 
absent, and remain bound to protein C23 when the nucleus 
reforms. This possibility is also ruled out because >95%  of 
those cells microinjected with protein C23 antibodies exhibit 
nucleolar  fluorescence  3  h  after  microinjection  (Fig.  3b). 
During this time period <18%  of the cells would have gone 
through mitosis. 
A  third  mechanism that  could account for the  nucleolar 
localization of microinjected protein C23  antibodies is that 
the antibodies bind to newly-synthesized protein C23 and are 
transported to the nucleolus complexed with protein C23. We 
excluded  this  possibility by  microinjecting affinity-purified 
antibodies into cells in which >90% of the protein synthesis 
was  inhibited  with  cycloheximide.  The  distribution  of the 
antibody in control and cycloheximide-treated cells was sim- 
ilar at 3 h and, as is shown in Fig.  5b, at  17 h after microin- 
jection. Thus, entry of microinjected antibodies into the nu- 
cleus does not appear to depend on protein synthesis. 
We consider more likely the possibility that antibodies can 
penetrate the nuclear envelope but are limited in their rate of 
entry by their size (2, 25). Nonimmune immunoglobulins do 
not bind nuclear structures but apparently equilibrate between 
the  nucleus  and  cytoplasm, perhaps as a  function  of their 
molecular size. Antibodies specific for nuclear proteins enter 
the  nucleus like nonspecific immunoglobins, but they bind 
nuclear proteins with the affinity typical of antigen-antibody 
reactions. Thus, we interpret the localization of antibodies to 
protein C23 in the nucleolus to reflect binding to nondiffusible 
nucleolar components. We do not know whether the accu- 
mulation of specific antibodies in the nucleolus is diffusion- 
limited or due to a  nuclear transport system. Feldherr et al. 
(l l)  have  recently  reported  that  the  nuclear  uptake  of a 
148,000-mol wt nuclear protein in  frog oocytes occurs at a 
rate greater than can be accounted for by simple diffusion. 
Accordingly, there may be a transport system responsible for 
the  nuclear  accumulation  of this  and  perhaps  other  high 
molecular weight proteins. 
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